dc.contributor.author | Takechi, Ryu | |
dc.contributor.author | Pallebage-Gamarallage, M. | |
dc.contributor.author | Galloway, S. | |
dc.contributor.author | Lam, V. | |
dc.contributor.author | Johnsen, R. | |
dc.contributor.author | Wellington, C. | |
dc.contributor.author | Mamo, J. | |
dc.date.accessioned | 2017-01-30T13:23:58Z | |
dc.date.available | 2017-01-30T13:23:58Z | |
dc.date.created | 2016-09-12T08:36:31Z | |
dc.date.issued | 2010 | |
dc.identifier.citation | Takechi, R. and Pallebage-Gamarallage, M. and Galloway, S. and Lam, V. and Johnsen, R. and Wellington, C. and Mamo, J. 2010. Probucol Reduces Enterocytic Amyloid-beta Relative to Chylomicron Apolipoprotein B in Mice Chronically Fed Saturated Fats, 2nd International Symposium of Chylomicrons in Disease, pp. 80-81: ELSEVIER IRELAND LTD. | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/31185 | |
dc.identifier.doi | 10.1016/j.atherosclerosissup.2010.04.036 | |
dc.publisher | ELSEVIER IRELAND LTD | |
dc.title | Probucol Reduces Enterocytic Amyloid-beta Relative to Chylomicron Apolipoprotein B in Mice Chronically Fed Saturated Fats | |
dc.type | Conference Paper | |
dcterms.source.volume | 11 | |
dcterms.source.startPage | 80 | |
dcterms.source.endPage | 81 | |
dcterms.source.issn | 1567-5688 | |
dcterms.source.title | ATHEROSCLEROSIS SUPPLEMENTS | |
dcterms.source.series | ATHEROSCLEROSIS SUPPLEMENTS | |
dcterms.source.conference | 2nd International Symposium of Chylomicrons in Disease | |
curtin.department | School of Public Health | |
curtin.accessStatus | Fulltext not available | |